LINC00632 and hepatocellular carcinoma: CDR1as additionally plays an oncogenic role in a range of tumor types including hepatocellular carcinoma [18–20], colorectal carcinoma [21], cholangiocarcinoma [22], esophageal squamous cell carcinoma [16], melanoma [23], non-small-cell lung cancer [24], laryngeal squamous cell carcinoma [25], and osteosarcoma [26].